Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Biochemistry and molecular biology

Inside the Lab Digital and computational pathology

Mutation Detective

| Luke Turner

A new algorithm finds that a quality control process to remove nonsense mutations in our immune system could be having an undesired effect

Diagnostics Genetics and epigenetics

What is the Real Impact?

| Sponsored by Thermo Fisher Scientific

How valuable can it be to receive fully automated NGS results in a single day? A group of experts share their views

Diagnostics Biochemistry and molecular biology

Cancer Trap

| Luke Turner

New synthetic scaffolds that sit under the skin and attract cancer cells could provide the earliest indication of metastasis

Diagnostics Biochemistry and molecular biology

Molecular Diagnostics on the Rise

| Michael Schubert

Accurate, safe, and dependable diagnostic tools are crucial – and this is where molecular diagnostics has the opportunity to shine

Diagnostics Biochemistry and molecular biology

Quick Hits

| Luke Turner

Read these bite-size breakthroughs to discover the latest research in the field of diagnostic medicine

Subspecialties Histology

Molecular Drivers of Mesothelioma

| Stefania Erra, Carolina Pelazza

A case series that explores the potential molecular contributors to pleural mesothelioma carcinogenesis – and its treatment options

Subspecialties Microbiology and immunology

A Whole New (Microbial) World

| Luke Turner

New research uncovers thousands of previously unidentified tiny proteins in the microbiome that could advance our understanding of human health

Subspecialties Cytology

A Better Future for Bladder Cancer

| John Cucci

A new immunocytochemistry stain offers a sensitive, noninvasive, and cost-effective diagnostic tool for patients at risk of bladder cancer

Subspecialties Cytology

Protecting Patients from Progression

| Michael Schubert

A new molecular test offers the first opportunity to identify the patients who are most likely to benefit from treatment, rather than surveillance

Diagnostics Genetics and epigenetics

Exploring the Epi-signature

| Luke Turner

New research shows that genome-wide testing of DNA methylation can diagnose previously unsolved cases of neurodevelopmental and congenital anomalies


Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register